Technical Analysis for TRHC - Tabula Rasa HealthCare, Inc.

Grade Last Price % Change Price Change
grade B 67.26 -1.07% -0.73
TRHC closed down 0.1 percent on Thursday, January 17, 2019, on 1.76 times normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Up
See historical TRHC trend table...

Date Alert Name Type % Chg
Jan 17 200 DMA Support Bullish -1.07%
Jan 17 50 DMA Support Bullish -1.07%
Jan 17 Stochastic Reached Overbought Strength -1.07%
Jan 17 Outside Day Range Expansion -1.07%
Jan 17 Overbought Stochastic Strength -1.07%
Jan 16 Crossed Above 50 DMA Bullish -1.18%
Jan 15 Crossed Above 200 DMA Bullish 3.57%
Jan 15 Crossed Above 20 DMA Bullish 3.57%
Jan 15 Inside Day Range Contraction 3.57%
Jan 14 Fell Below 200 DMA Bearish 9.72%

Older signals for TRHC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Tabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient's acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.
Is TRHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 15 TRHC Commends Centers for Medicare and Medicaid Services on Creation of New Opportunities for Dual Medicaid and Medicare Patients
Jan 11 Tabula Rasa completes $20M acquisition of Australian medical software company
Jan 8 Benchmark sees 31% upside in Tabula Rasa in premarket analyst action
Jan 7 Tabula Rasa HealthCare Completes Acquisition of DoseMe
Dec 28 CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?
Dec 20 Should You Be Worried About Insider Transactions At Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?
Dec 19 Tabula Rasa Healthcare appoints Kevin Boesen as Chief Sales Officer
Dec 19 Tabula Rasa HealthCare Appoints Kevin Boesen as Chief Sales Officer
Dec 6 Tabula Rasa To Acquire DoseMe For Dosing Software
Dec 4 $20 million deal: Tabula Rasa reaches agreement to buy Australian med tech company
See more TRHC news...
Indicators
Indicator Value
52 Week High 91.16
52 Week Low 28.55
Average Volume 286,905
200-Day Moving Average 64.558
50-Day Moving Average 66.9632
20-Day Moving Average 62.9175
10-Day Moving Average 65.279
Average True Range 4.0013
ADX 20.45
+DI 19.0939
-DI 25.7555
Chandelier Exit (Long, 3 ATRs ) 57.4361
Chandelier Exit (Short, 3 ATRs ) 67.6039
Upper Bollinger Band 69.6843
Lower Bollinger Band 56.1507
Percent B (%b) 0.87
BandWidth 21.510073
MACD Line -0.248
MACD Signal Line -1.1186
MACD Histogram 0.8706
Fundamentals Value
Market Cap 1.18 Billion
Num Shares 17.3 Million
EPS -0.82
Price-to-Earnings (P/E) Ratio -82.91
Price-to-Sales 4.15
Price-to-Book 8.10
PEG Ratio 2.68
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 75.58
Resistance 3 (R3) 74.78 71.44 74.32
Resistance 2 (R2) 71.44 69.51 71.85 73.89
Resistance 1 (R1) 69.72 68.32 70.58 70.52 73.47
Pivot Point 66.38 66.38 66.82 66.79 66.38
Support 1 (S1) 64.66 64.45 65.52 65.46 62.51
Support 2 (S2) 61.32 63.26 61.73 62.09
Support 3 (S3) 59.60 61.32 61.67
Support 4 (S4) 60.40